Kevin Patrick Moran - Net Worth and Insider Trading
Kevin Patrick Moran Net Worth
The estimated net worth of Kevin Patrick Moran is at least $1 Million dollars as of 2024-11-05. Kevin Patrick Moran is the SVP, CFO & Treasurer of Vanda Pharmaceuticals Inc and owns about 229,398 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $1 Million. Details can be seen in Kevin Patrick Moran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Patrick Moran has not made any transactions after 2024-07-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Patrick Moran
Kevin Patrick Moran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Patrick Moran owns 1 companies in total, including Vanda Pharmaceuticals Inc (VNDA) .
Click here to see the complete history of Kevin Patrick Moran’s form 4 insider trades.
Insider Ownership Summary of Kevin Patrick Moran
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VNDA | Vanda Pharmaceuticals Inc | 2024-07-29 | VP & Acting CFO & Treasurer |
Kevin Patrick Moran Latest Holdings Summary
Kevin Patrick Moran currently owns a total of 1 stock. Kevin Patrick Moran owns 229,398 shares of Vanda Pharmaceuticals Inc (VNDA) as of July 29, 2024, with a value of $1 Million.
Latest Holdings of Kevin Patrick Moran
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VNDA | Vanda Pharmaceuticals Inc | 2024-07-29 | 229,398 | 4.68 | 1,072,436 |
Holding Weightings of Kevin Patrick Moran
Kevin Patrick Moran Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Patrick Moran has made a total of 9 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 2,251 shares on July 29, 2024, which brought Kevin Patrick Moran around $13,326.
Insider Trading History of Kevin Patrick Moran
- 1
Kevin Patrick Moran Trading Performance
Kevin Patrick Moran Ownership Network
Ownership Network List of Kevin Patrick Moran
Ownership Network Relation of Kevin Patrick Moran
Kevin Patrick Moran Owned Company Details
What does Vanda Pharmaceuticals Inc do?
Who are the key executives at Vanda Pharmaceuticals Inc?
Kevin Patrick Moran is the VP & Acting CFO & Treasurer of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include SVP & General Counsel Timothy Williams , director & Chief Executive Officer Mihael Hristos Polymeropoulos , and SVP & Chief Marketing Officer Joakim Wijkstrom .
Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary
Over the past 18 months, Kevin Patrick Moran made 4 insider transaction in Vanda Pharmaceuticals Inc (VNDA) with a net sale of 35,163. Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 31,688 shares made by Timothy Williams , a net sale of 20,451 shares made by Joakim Wijkstrom , and a net sale of 55,172 shares made by Mihael Hristos Polymeropoulos .
In summary, during the past 3 months, insiders sold 0 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 166,385 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 166,385 shares.
Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vanda Pharmaceuticals Inc Insider Transactions
Kevin Patrick Moran Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Patrick Moran. You might contact Kevin Patrick Moran via mailing address: C/o Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300e, Washington Dc 20037.